Patents Represented by Attorney Hans L. Berneis
  • Patent number: 3987052
    Abstract: 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines of the formula (IV): ##SPC1##wherein R is selected from the group consisting of hydrogen, alkyl of 1 to 3 carbon atoms, inclusive, phenyl, benzyl and -COOR' in which R' is alkyl of 1 to 4 carbon atoms, inclusive; wherein R.sub.1 is selected from the group consisting of hydrogen and alkyl of 1 to 3 carbon atoms, inclusive; and wherein R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are selected from the group consisting of hydrogen, alkyl of 1 to 3 carbon atoms, inclusive, halogen, nitro, cyano, trifluoromethyl, and alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkanoylamino and dialkylamino in which the carbon chain moieties are of 1 to 3 carbon atoms, inclusive, are produced by condensing a 1,3-dihydro-5-phenyl-2H-1,4-benzodiazepine-2-thione of the formula (I): ##SPC2## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are defined as above, with an organic acid hydrazide of the formula: ##EQU1## wherein R is defined as above.
    Type: Grant
    Filed: October 29, 1969
    Date of Patent: October 19, 1976
    Assignee: The Upjohn Company
    Inventor: Jackson B. Hester, Jr.
  • Patent number: 3966736
    Abstract: 2,9-Dihydro-3H-pyrido[3,2-c]-s-triazolo[4,3-a][1,5]-benzodiazepin-3-ones ##SPC1##Wherein R' and R" are alkyl of 1 to 3 carbon atoms, inclusive; or the group ##EQU1## together is pyrrolidino, piperidino, 4-methylpiperazino or [4-(2-hydroxyethyl)]piperazino; wherein R.sub.2 and R.sub.3 are hydrogen, chloro, bromo, trifluoromethyl, or alkyl defined as above and wherein R.sub.4 is hydrogen, alkyl as defined above or ##EQU2## in which n is the integer 2 or 3 or R', R" or ##EQU3## are defined as above, are obtained by reacting a compound of the formula 1 ##SPC2##Wherein R.sub.2, R.sub.3, R', R", or ##EQU4## are defined as above, with phosphorus pentasulfide to give the corresponding 5-thione compound (II); treating II with an alkyl carbazate to obtain the compound of formula III: ##SPC3##wherein R.sub.2, and R.sub.
    Type: Grant
    Filed: April 7, 1975
    Date of Patent: June 29, 1976
    Assignee: The Upjohn Company
    Inventor: Jacob Szmuszkovicz
  • Patent number: 3957761
    Abstract: A multistep process for the production of a compound of the formula V: ##SPC1##wherein R' and R" are alkyl of 1 to 3 carbon atoms, inclusive or together ##EQU1## is pyrrolidino, piperidino, 4-methylpiperazino or morpholino; and wherein the rings A and B are unsubstituted, or substituted by one or more substituents selected from the group consisting of fluoro, chloro, bromo, nitro and trifluoromethyl, which comprises treating an equivalent of a compound of formula 1: ##SPC2##Wherein rings A and B are defined as above, with 2 equivalents of an .alpha.
    Type: Grant
    Filed: June 19, 1974
    Date of Patent: May 18, 1976
    Assignee: The Upjohn Company
    Inventors: Martin Gall, Jackson B. Hester, Jr.
  • Patent number: 3956297
    Abstract: 9H-Dibenzoimidazodiazepine compounds of the formula: ##SPC1##Wherein R.sub.1 is hydrogen, alkyl, ##SPC2##In which W is H, chlorine, or fluorine, or R.sub.1 is ##EQU1## IN WHICH N IS AN INTEGER OF 2 TO 4, AND R.sub.o ' and R.sub.o ' are hydrogen or alkyl defined as above, or together ##EQU2## IS PYRROLIDINO, PIPERIDINO, N-methylpiperazino, or morpholino, wherein R.sub.3 and R.sub.4 are hydrogen or alkyl as defined above, or, R.sub.3 or R.sub.4 can be ##EQU3## IN WHICH ##EQU4## IS DEFINED AS ABOVE AND WHEREIN R.sub.2 and R.sub.6 are selected from the group consisting of hydrogen, halogen, or -CF.sub.3, are produced by multistep reactions.The compounds of the formula above and the pharmacologically acceptable acid addition salts thereof are useful sedatives and anti-depressants. They can also be administered to mammals to alleviate anxieties and produce tranquilization and sedation.
    Type: Grant
    Filed: October 2, 1974
    Date of Patent: May 11, 1976
    Assignee: The Upjohn Company
    Inventor: Martin Gall
  • Patent number: 3947466
    Abstract: A multi-step process for the preparation of 1-[(amino - or substituted amino)methyl]-6-phenyl-4H-s-triazolo-[4,3-a][1,4]benzodiazepines of the formula VI: ##SPC1##wherein R' is hydrogen or alkyl of 1 to 3 carbon atoms, inclusive, and wherein the rings A and B are unsubstituted or substituted by one or two substituents selected from the group consisting of chloro, fluoro, bromo, nitro, and trifluoromethyl, which comprises: treating a compound of the formula I: ##SPC2##wherein rings A and B are defined as above, with acetic anhydride and formic acid to obtain compound II: ##SPC3##wherein A and B rings have the significance as above, treating compound II with sufficient formaldehyde to produce compound III, the 3,5-bis(hydroxymethyl)derivative of II; treating III with phthalimide, triphenylphosphine and diethyl azodicarboxylate to give compound IV, the 3,5-bis(phthalimidomethyl) derivative of II; and treating IV with hydrazine hydrate to obtain a compound of formula V ##SPC4##wherein rings A and B are defined, a
    Type: Grant
    Filed: June 19, 1974
    Date of Patent: March 30, 1976
    Assignee: The Upjohn Company
    Inventors: Martin Gall, Jackson B. Hester, Jr.
  • Patent number: 3941802
    Abstract: Compounds of the formulae IV and V: ##SPC1##wherein R.sub.o and R.sub.1 are hydrogen or alkyl of 1 to 3 carbon atoms, inclusive; wherein R.sub.2 is hydrogen, fluoro, chloro, or trifluoromethyl; wherein R.sub.3 is hydrogen or fluoro with the proviso that R.sub.3 cannot be fluoro, if R.sub.2 is chloro or trifluoromethyl; and wherein R.sub.4 is hydrogen, fluoro, chloro, bromo, trifluoromethyl, or nitro, are obtained by a multi-step reaction from the corresponding .alpha.-(phenyl)-o-toluidine of the formula I ##SPC2##wherein R.sub.2, R.sub.3, and R.sub.4 are defined as above, by treating I in sequence with an alkyl ester of orthoformic acid the resulting product with 2-alkyl-2-(aminoalkyl)-1,3-dioxolane or a 2-amino-alkanone dialkyl ketal and finally with titanium tetrachloride to obtain compound IV, and oxidizing compound IV to obtain the corresponding compound V.Compounds IV and V have minor tranquilizing activity which can be utilized to calm mammals or birds.
    Type: Grant
    Filed: April 4, 1975
    Date of Patent: March 2, 1976
    Assignee: The Upjohn Company
    Inventor: Martin Gall
  • Patent number: 3941803
    Abstract: Compounds of formula II ##SPC1##and its phthalimide derivative III: ##SPC2##wherein R.sub.0 and R.sub.1 are hydrogen or alkyl of 1 to 3 carbon atoms, inclusive; wherein R.sub.2 is hydrogen, chloro, fluoro, or trifluoromethyl; wherein R.sub.3 is hydrogen, or fluoro with the proviso that R.sub.3 is not fluoro, if R.sub.2 is chloro or trifluoromethyl; and wherein R.sub.4 is hydrogen, fluoro, chloro, bromo, nitro, or trifluoromethyl are prepared by reacting a compound of formula I: ##SPC3##wherein R.sub.0, R.sub.1, R.sub.2, R.sub.3, and R.sub.4 are defined as above, with formaldehyde to produce compound II and reacting II with phthalimide, triphenylphosphine and finally diethyl azodicarboxylate to give compound III.Compounds II and III are useful as important intermediates for the production of known 6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepine which compounds are active as tranquilizers and antianxiety agents.
    Type: Grant
    Filed: March 28, 1975
    Date of Patent: March 2, 1976
    Assignee: The Upjohn Company
    Inventor: Martin Gall
  • Patent number: 3933816
    Abstract: A compound of the formula: ##SPC1##Wherein R, R.sub.0, and R.sub.3 are hydrogen or alkyl of 1 to 3 carbon atoms, inclusive; wherein R.sub.1 and R.sub.2 are alkyl of 1 to 3 carbon atoms, or the group ##EQU1## together is pyrrolidino, piperidino, morpholino and N-methylpiperazino; wherein R.sub.7 is 2-pyridyl or a phenyl radical of the formula ##SPC2##Wherein R.sub.4 is hydrogen, fluoro, or chloro; wherein R.sub.5 is hydrogen or fluoro, with the proviso that R.sub.5 is not fluoro, when R.sub.4 is chloro; and wherein R.sub.6 is hydrogen, chloro, fluoro, bromo, trifluoromethyl, or nitro.The new compounds of formula II have tranquilizing and antianxiety activity and are thus useful to treat mammals and birds.
    Type: Grant
    Filed: September 12, 1974
    Date of Patent: January 20, 1976
    Assignee: The Upjohn Company
    Inventor: Jacob Szmuszkovicz